A Multi-center, phase 1/2 open label study of Selinexor (KPT-330), Lenalidomide, and Dexamethasone in patients with R/R MM
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
July 15, 2015
End Date
September 13, 2017
Administered By
Duke Cancer Institute
Awarded By
Karyopharm Therapeutics
Start Date
July 15, 2015
End Date
September 13, 2017